Mabwell's clinical trial application for 9MW5211 cleared by US FDA
Curocell secures full approval for RIMQARTO to enter CAR-T therapy market
HUTCHMED secures priority review for sovleplenib NDA in China
Circio partners with Acuitas to evaluate in vivo CAR-T cell therapy technology
Asgard Therapeutics appoints chief medical officer
Thermo Fisher Scientific unveils CHOvantage GS Kit to speed biologics development
Galapagos and Gilead expand collaboration to advance T cell engager programme
Aurinia Pharmaceuticals agrees to acquire Kezar Life Sciences
Thermo Fisher Scientific and SHL Medical launch integrated US drug-device manufacturing
Immunic granted European patent for vidofludimus calcium dosing regimens
Sanofi's rilzabrutinib receives orphan drug designation in Japan for IgG4-related disease
Johnson & Johnson submits sBLA to FDA for first-ever treatment for wAIHA
Genentech reports positive Phase III MAJESTYdata for Gazyva in primary membranous nephropathy
STADA and Bio-Thera Solutions receive European marketing authorisation for Gotenfia (golimumab)